Biogaia

Biogaia Operating Cash Flow

The Operating Cash Flow of Biogaia (BIOG B.ST) as of Nov 21, 2026 is 306.57 M SEK. In the previous year, Operating Cash Flow was 373.22 M SEK — a change of -17.86% (lower).

Operating Cash Flow

306.57 MSEK

YoY

-17.86%

Last updated:

Operating Cash Flow of Biogaia is 2025 306.57 M SEK. Operating Cash Flow of Biogaia was 2024 373.22 M SEK. It decreases by -17.86% lower compared to the previous year.

The Biogaia Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
183.12 M SEK
Jan 1, 2019
147.86 M SEK
Jan 1, 2020
221.26 M SEK
Jan 1, 2021
221.88 M SEK
Jan 1, 2022
318.94 M SEK
Jan 1, 2023
425.97 M SEK
Jan 1, 2024
373.22 M SEK
Jan 1, 2025
306.57 M SEK
The Biogaia Operating Cash Flow history
YEAROperating Cash FlowYoY
306.57 MSEK-17.86%
373.22 MSEK-12.38%
425.97 MSEK+33.56%
318.94 MSEK+43.75%
221.88 MSEK+0.28%
221.26 MSEK+49.64%
147.86 MSEK-19.26%
183.12 MSEK-17.74%
222.62 MSEK+50.49%
147.93 MSEK+25.90%
117.50 MSEK-5.53%
124.38 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

Operating Cash Flow of Biogaia is 306.57 M SEK in 2025.

Operating Cash Flow of Biogaia changed from 373.22 M SEK to 306.57 M SEK, representing a -17.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Biogaia since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Biogaia historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Biogaia

All Key Metrics — Biogaia